Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02897765
Recruitment Status : Active, not recruiting
First Posted : September 13, 2016
Last Update Posted : November 29, 2019
Bristol-Myers Squibb
Information provided by (Responsible Party):
Neon Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2020